Who owns HAEMONETICS?

Tip: Access positions for across all investors

Analyze quarterly positions in Haemonetics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Haemonetics stock

Who bought or sold HAEMONETICS this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Tenor Capital Management 48M $45B 43% Sep 2024
 View chart
Franklin Resources 35M $33M 0% Sep 2024
 View chart
MacKay Shields 27M $25M -1% Sep 2024
 View chart
Aviva 25M $22M 2% Jun 2024
 View chart
Osterweis Capital Management 18M $16M 0% Jun 2024
 View chart
Readystate Asset Management 16M $15M 0% Sep 2024
 View chart
Braidwell 12M $11M 0% Sep 2024
 View chart
Wells Fargo & Company 8.3M $7.7M -40% Sep 2024
 View chart
Lazard Asset Management 7.5M $7.0M 0% Sep 2024
 View chart
Oaktree Capital Management 6.6M $6.1M -22% Sep 2024
 View chart
State Street Corporation 6.5M $5.9M -39% Jun 2024
 View chart
Kohlberg Kravis Roberts & Co 4.2M $3.8M 81% Jun 2024
 View chart
SSI Investment Management 4.0M $3.7M 14% Sep 2024
 View chart
Bnp Paribas Investment Partners 4.0M $3.7M -33% Sep 2024
 View chart
BlackRock 3.9M $3.5M -10% Jun 2024
 View chart
DeepCurrents Investment Group 3.6M $3.3M -86% Jun 2024
 View chart
D. E. Shaw & Co 3.3M $3.1M 100% Sep 2024
 View chart
BlackRock 3.2M $2.9M 100% Sep 2024
 View chart
Toronto-Dominion Bank 3.0M $2.8M 0% Sep 2024
 View chart
Daiwa Securities Group 2.5M $2.3M 100% Sep 2024
 View chart
Aequim Alternative Investments 2.5M $2.3M 0% Sep 2024
 View chart
Palisade Capital Management 2.4M $2.2M 100% Jun 2024
 View chart
Ontario Teachers' Pension Plan Board 2.0M $1.8M 0% Sep 2024
 View chart
CSS 2.0M $1.9M 100% Sep 2024
 View chart
Russell Investments 1.6M $1.4M -44% Jun 2024
 View chart
Leucadia National Corporation 1.4M $1.3M 8675% Jun 2024
 View chart
Verition Fund Management 1.2M $1.0M -86% Jun 2024
 View chart
Corbyn Investment Management 604k $556k 18% Sep 2024
 View chart
Invesco 450k $414k 0% Sep 2024
 View chart
Zazove Associates 382k $355k 1636% Sep 2024
 View chart
Sei Investments 335k $308k 0% Sep 2024
 View chart
American Century Companies 325k $301k -9% Sep 2024
 View chart
Calamos Advisors 313k $291k 6% Sep 2024
 View chart
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 250k $232k -88% Sep 2024
 View chart
Oppenheimer Asset Management 208k $191k -5% Sep 2024
 View chart
Jpmorgan Chase & Co 166k $154k -55% Sep 2024
 View chart
Stephens 108k $99k -7% Sep 2024
 View chart
LPL Financial 48k $44k 100% Sep 2024
 View chart
Balboa Wealth Partners 38k $35k 0% Sep 2024
 View chart
Jane Street 34k $31k -32% Sep 2024
 View chart
Sontag Advisory 21k $19k 100% Sep 2024
 View chart
Commonwealth Equity Services 10k $9.0k 100% Sep 2024
 View chart
Us Bancorp 6.0k $5.5k 100% Sep 2024
 View chart
Barclays 5.0k $5.0k -100% Sep 2024
 View chart
Brown Trout Management 2.3k $2.1M 0% Sep 2024
 View chart

Who sold out of Haemonetics?

Fund or Company Name Date Sold Shares Held Valued At
Citigroup Jun 2024 5.6M $5.1M
Bank of America Corporation Jun 2024 3.6M $3.2M
Citadel Advisors Jun 2024 2.0M $1.8M
Quaero Capital Jun 2024 1.2M $1.1M
Advent Capital Management Jun 2024 7.0k $6.3k